Dhanalakshmi Sivanandhan, Mallikarjuna G U, Singh Rana P, Agarwal Rajesh
Department of Pharmaceutical Sciences, School of Pharmacy, University of Colorado Health Sciences Center, Denver, CO 80262, USA.
Carcinogenesis. 2004 Aug;25(8):1459-65. doi: 10.1093/carcin/bgh152. Epub 2004 Mar 19.
Non-melanoma skin cancer (NMSC) accounts for >1 million new cases each year in the US alone suggesting that more approaches are needed for its prevention and control. Earlier studies by us have shown that silymarin (a crude form of biologically active silibinin with some other isomers), isolated from milk thistle, affords strong protection against ultraviolet (UV) radiation-induced NMSC in SKH-1 hairless mice; however, the molecular mechanisms of its efficacy are not known. Here, we assessed the effect of silibinin on UV-induced DNA damage and p53-p21/Cip1 accumulation, and their roles in UV-induced cell proliferation and apoptosis in SKH-1 hairless mouse epidermis. Topical application of silibinin prior to, or immediately after, UV irradiation resulted in a very strong protective effect against UV-induced thymine dimer positive cells in epidermis accounting for 76-85% (P < 0.001) inhibition. In other studies, silibinin treatment resulted in a further up-regulation of p53 by approximately 1.6-fold (P < 0.001) together with an increase ( approximately 2-fold, P < 0.001) in p21/Cip1 protein levels. Proliferative cell nuclear antigen staining showed that silibinin pre- or post-topical application significantly inhibits (40-52 and 20-40%, respectively, P < 0.001) UV-induced epidermal cell proliferation. In addition, silibinin strongly decreased UV-caused terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling-positive apoptotic/sunburn cell formation (P < 0.001). These findings suggest that silibinin affords strong protection against UV-induced damage in epidermis by a decrease in thymine dimer positive cells and an up-regulation of p53-p21/Cip1 possibly leading to an inhibition in both cell proliferation and apoptosis. Comparable effects of silibinin following its pre- or post-UV application suggest that mechanisms other than sunscreen effect are operational in silibinin efficacy against UV-caused skin damages.
仅在美国,每年非黑色素瘤皮肤癌(NMSC)的新发病例就超过100万,这表明需要更多的方法来预防和控制该病。我们早期的研究表明,从水飞蓟中分离出的水飞蓟素(一种具有生物活性的水飞蓟宾粗品及其他一些异构体)能为SKH - 1无毛小鼠提供强大的保护,使其免受紫外线(UV)辐射诱导的NMSC;然而,其疗效的分子机制尚不清楚。在此,我们评估了水飞蓟宾对紫外线诱导的DNA损伤和p53 - p21/Cip1积累的影响,以及它们在紫外线诱导的SKH - 1无毛小鼠表皮细胞增殖和凋亡中的作用。在紫外线照射之前或之后立即局部应用水飞蓟宾,对紫外线诱导的表皮胸腺嘧啶二聚体阳性细胞产生了非常强的保护作用,表皮中胸腺嘧啶二聚体阳性细胞的抑制率为76 - 85%(P < 0.001)。在其他研究中,水飞蓟宾处理导致p53进一步上调约1.6倍(P < 0.001),同时p21/Cip1蛋白水平增加(约2倍,P < 0.001)。增殖细胞核抗原染色显示,局部应用水飞蓟宾预处理或后处理均能显著抑制(分别为40 - 52%和20 - 40%,P < 0.001)紫外线诱导的表皮细胞增殖。此外,水飞蓟宾强烈减少了紫外线导致的末端脱氧核苷酸转移酶介导的dUTP缺口末端标记阳性凋亡/晒伤细胞的形成(P < 0.001)。这些发现表明,水飞蓟宾通过减少胸腺嘧啶二聚体阳性细胞和上调p53 - p21/Cip1,为表皮提供了强大的保护,使其免受紫外线诱导的损伤,这可能导致细胞增殖和凋亡均受到抑制。紫外线照射前或后应用水飞蓟宾产生的类似效果表明,除防晒作用外,其他机制在水飞蓟宾对紫外线引起的皮肤损伤的疗效中起作用。